Insulin‐Loaded Muco‐Inert Nanoparticles Based on L ‐valine‐modified Chitosan and Fucoidan for Enhanced Oral Delivery
Macromolecular Bioscience · 2026
DOI: 10.1002/mabi.202500586 ↗Kurz gefasst
Fachartikel in der Zeitschrift Macromolecular Bioscience, 2026. Verfasst von Changsheng Gan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Engineering Research Center of Bio-process, Ministry of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, …. Hauptthemen laut MEDLINE: Chitosan, Insulin, Polysaccharides, Nanoparticles. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Enterprise Project of Anhui Dexinjia Biopharm Co., Ltd.
Abstract (Originalsprache)
Oral delivery of insulin faces significant challenges due to various barriers present in the gastrointestinal tract, leading to minimal therapeutic outcomes. To overcome these obstacles, chitosan‐based nanoparticles modified by L ‐valine were designed and subsequently coated with fucoidan (FU) to improve the permeation efficiency through the mucus layer and intestinal epithelium. The insulin‐loaded nanoparticles were characterized by dynamic light scattering (DLS), transmission electron microscopy (TEM), encapsulation efficiency (EE), and loading capacity (LC). The prepared nanoparticles VCS‐INS‐FU NPs, formed by L ‐valine‐grafted chitosan (VCS) and fucoidan, can effectively resist the degradation of insulin by digestive enzymes and exhibit a sustained release profile of encapsulated insulin. Mucoadhesion tests revealed that the nanoparticles VCS‐INS‐FU NPs (INS/FU 1: 2) had significant mucus permeability. Furthermore, VCS‐INS‐FU NPs exhibited an enhanced capability for cellular internalization by cellular uptake studies using confocal laser scanning microscopy (CLSM). In vivo studies demonstrated that the oral insulin delivery system produced a pronounced and long‐lasting hypoglycemia effect in diabetic mice. In conclusion, the muco‐inert nanocomplex based on L ‐valine‐modified chitosan and fucoidan presents a promising platform for effective oral insulin delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Engineering Research Center of Bio-process, Ministry of Education, School of Food and Biological Engineering, Hefei University of Technology, Hefei, Anhui, P R China.
- Anhui Dexinjia Biopharm Co., Ltd, Taihe, Anhui, P R China.
ORCID-Profile: Changsheng Gan
Förderung
- Enterprise Project of Anhui Dexinjia Biopharm Co., Ltd
Zitieren
APA
Gan, C., Li, H., Yang, L., Zhang, T., Xu, K., Wang, H., Sun, S., Yuan, C., Hui, A., & Zhang, W. (2026). Insulin‐Loaded Muco‐Inert Nanoparticles Based on L ‐valine‐modified Chitosan and Fucoidan for Enhanced Oral Delivery. Macromolecular Bioscience. https://doi.org/10.1002/mabi.202500586
Vancouver
Gan C, Li H, Yang L, Zhang T, Xu K, Wang H, et al. Insulin‐Loaded Muco‐Inert Nanoparticles Based on L ‐valine‐modified Chitosan and Fucoidan for Enhanced Oral Delivery. Macromolecular Bioscience. 2026. doi:10.1002/mabi.202500586
BibTeX
@article{Gan2026,
author = {Gan, Changsheng and Li, Huiya and Yang, Liu and Zhang, Tianling and Xu, Kun and Wang, Honglei and Sun, Shiji and Yuan, Chuanxun and Hui, Ailing and Zhang, Wencheng},
title = {Insulin‐Loaded Muco‐Inert Nanoparticles Based on L ‐valine‐modified Chitosan and Fucoidan for Enhanced Oral Delivery},
journal = {Macromolecular Bioscience},
year = {2026},
doi = {10.1002/mabi.202500586}
}
EUVIMED